BB Biotech Confirms Profit and Lowers Dividend

finews.ch

Factuality

Ownership

BB Biotech, which specialises in the pharmaceutical sector, has confirmed its preliminary figures for fiscal year 2024. Looking ahead, more activity is expected. There is uncertainty about the regulatory framework in the USA.

finews.com

Factuality

Ownership

BB Biotech Confirms Profit and Lowers Dividend

The investment company BB Biotech, which specializes in the pharmaceutical sector, has confirmed its preliminary figures for the 2024 financial year. Looking ahead, increased activity is expected. However, there is uncertainty regarding regulatory conditions in the United States.

Moneycab

Factuality

Ownership

The holding company BB Biotech feels a structural recovery in the biotech sector and concluded with a profit in 2024. This is confirmed by the company on Friday with the final figures.